Effect of Body Position and Probe Position on the Localization of Breast Mass

Stopped early

Conditions studied: Breast Diseases

In brief

The purpose of this study is to demonstrate that BVN G-1000 can precisely and consistently measure the position of female breast lesions regardless of patient rotation and probe angle during ultrasound examination.

Key facts

Study ID

NCT02997540

Run by

MetriTrack, Inc.

People needed

20

Starts

2016-11-01

Expected to finish

2020-01-01

Last updated by the study team

2021-07-21

Who can join

Age: 21 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female
• 21-70 years of age
• Known palpable or non-palpable benign or probably benign breast mass or masses, less than 2 cm in maximum diameter and at least 4 cm away from the nipple, from a previous ultrasound examination

You may not qualify if…

• Women with cardiac pacemaker or portable defibrillator
• Women with known breast cancer or suspicious lesions
• Pregnant and lactating women
• Women who have breast implant(s)
• Women who have had prior breast surgical intervention not including breast needle biopsy, in the same breast with the qualifying target mass.
• Women with the target finding to be mapped within a distance of 4 cm from patient's nipple.
• Women with multiple similar qualifying targets in close proximity (less than 4 cm between targets).
• Women with history of allergy to medical-grade adhesive tape or ultrasound gel
• Women whose weight is over 250 pounds

Where it is running

• Evanston Hospital — Evanston, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.